For: | Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [PMID: 35646264 DOI: 10.4254/wjh.v14.i4.682] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i4/682.htm |
Number | Citing Articles |
1 |
Jing Qian, Shun‐zhong Gu, Yong‐jin Yan. Determination of rivaroxaban in rat plasma by ultra‐high‐performance liquid chromatography–Q‐Orbitrap high‐resolution mass spectrometry and its application to a pharmacokinetic study. Biomedical Chromatography 2022; 36(12) doi: 10.1002/bmc.5491
|
2 |
Nicoletta Riva, Walter Ageno. How to manage splanchnic vein thrombosis in patients with liver disease. Hematology 2023; 2023(1): 281 doi: 10.1182/hematology.2023000481
|
3 |
Aitor Odriozola, Ángela Puente, Antonio Cuadrado, Coral Rivas, Ángela Anton, Francisco José González, Raúl Pellón, Emilio Fábrega, Javier Crespo, José Ignacio Fortea. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. Journal of Clinical Medicine 2022; 11(21): 6435 doi: 10.3390/jcm11216435
|
4 |
Giovanni Monaco, Luca Bucherini, Bernardo Stefanini, Fabio Piscaglia, Francesco Giuseppe Foschi, Luca Ielasi. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art. World Journal of Gastroenterology 2023; 29(33): 4962-4974 doi: 10.3748/wjg.v29.i33.4962
Abstract(336) |
Core Tip(291) |
Full Article(HTML)(1706)
|
Full Article with Cover (PDF)-1212K(80)
|
Full Article (Word)-143K(26)
|
Audio-313K(4)
|
Peer-Review Report-236K(32)
|
Answering Reviewers-568K(31)
|
Full Article (PDF)-462K(236)
|
Full Article (XML)-258K(25)
|
Times Cited (1)
|
Total Visits (3860)
|
Open
|
5 |
Xia Ren, Yuan Huang, LiPing Ying, JinBo Wang. Risk factors of venous thromboembolism for liver tumors: a systematic review and meta-analysis. HPB 2024; 26(1): 1 doi: 10.1016/j.hpb.2023.09.008
|